Brief: Autolus Therapeutics Reports Second Quarter 2026 Financial Results And Business Updates
11/08/2026 12:51
BRIEF-Autolus Therapeutics Reports Second Quarter 2026 Financial Results And Business Updates Aug 11 (Reuters) - Autolus Therapeutics PLC 6A3Ay.F:
AUTOLUS THERAPEUTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATES
AUTOLUS THERAPEUTICS - INCREASES FY2026 NET PRODUCT REVENUE GUIDANCE TO $140-$150 MILLION
AUTOLUS THERAPEUTICS - Q2 2026 NET PRODUCT REVENUE $45.70 MILLION VERSUS $20.90 MILLION IN Q2 2025
AUTOLUS THERAPEUTICS - Q2 2026 NET LOSS $39.10 MILLION VERSUS $47.90 MILLION IN Q2 2025
Source text: ID:nGNX9QR98w
Further company coverage: [6A3Ay.F]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics Reports Second Quarter 2026 Financial Results And Business Updates
Brief: Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue
Brief: Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors